133 related articles for article (PubMed ID: 29446702)
1. How Does Usage of Serotonin Noradrenaline Reuptake Inhibitors Affect Intraocular Pressure in Depression Patients?
Uçan Gündüz G; Parmak Yener N; Kılınçel O; Gündüz C
J Ocul Pharmacol Ther; 2018 May; 34(4):354-359. PubMed ID: 29446702
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective serotonin reuptake inhibitors on intraocular pressure and anterior segment parameters in open angle eyes.
Gündüz GU; Parmak Yener N; Kılınçel O; Gündüz C
Cutan Ocul Toxicol; 2018 Mar; 37(1):36-40. PubMed ID: 28504010
[TBL] [Abstract][Full Text] [Related]
3. Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive Disorder.
Işik-Ulusoy S; Ulusoy MO
J Clin Psychopharmacol; 2021 Jan/Feb 01; 41(1):49-52. PubMed ID: 33347023
[TBL] [Abstract][Full Text] [Related]
4. The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.
Bellantuono C; Vargas M; Mandarelli G; Nardi B; Martini MG
Hum Psychopharmacol; 2015 May; 30(3):143-51. PubMed ID: 25784291
[TBL] [Abstract][Full Text] [Related]
5. First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.
Lassen D; Ennis ZN; Damkier P
Basic Clin Pharmacol Toxicol; 2016 Jan; 118(1):32-6. PubMed ID: 26435496
[TBL] [Abstract][Full Text] [Related]
6. Steroidogenic disruptive effects of the serotonin-noradrenaline reuptake inhibitors duloxetine, venlafaxine and tramadol in the H295R cell assay and in a recombinant CYP17 assay.
Islin J; Munkboel CH; Styrishave B
Toxicol In Vitro; 2018 Mar; 47():63-71. PubMed ID: 29100959
[TBL] [Abstract][Full Text] [Related]
7. Differences in the placebo response in duloxetine and venlafaxine trials.
Breilmann J; Furukawa TA; Becker T; Koesters M
Acta Psychiatr Scand; 2018 Jun; 137(6):472-480. PubMed ID: 29603140
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Pupillary Dilation on Intraocular Pressure and Anterior Segment Morphology in Subjects with and without Pseudoexfoliation.
Atalay E; Tamçelik N; Cicik ME
Curr Eye Res; 2015 May; 40(6):646-52. PubMed ID: 25197765
[TBL] [Abstract][Full Text] [Related]
9. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
10. Differences in the antinociceptive effects of serotonin-noradrenaline reuptake inhibitors via sodium channel blockade using the veratrine test in mice.
Yoshizawa K; Suzuki Y; Nakamura T; Takahashi Y; Makino K; Takahashi H
Neuroreport; 2021 Jun; 32(9):797-802. PubMed ID: 33994525
[TBL] [Abstract][Full Text] [Related]
11. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
12. Venlafaxine ER Blocks the Norepinephrine Transporter in the Brain of Patients with Major Depressive Disorder: a PET Study Using [18F]FMeNER-D2.
Arakawa R; Stenkrona P; Takano A; Svensson J; Andersson M; Nag S; Asami Y; Hirano Y; Halldin C; Lundberg J
Int J Neuropsychopharmacol; 2019 Apr; 22(4):278-285. PubMed ID: 30649319
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Anterior Segment Parameter Changes Using the Sirius after Uneventful Phacoemulsification.
Şimşek A; Bilgin B; Çapkın M; Bilak Ş; Güler M; Reyhan AH
Korean J Ophthalmol; 2016 Aug; 30(4):251-7. PubMed ID: 27478351
[TBL] [Abstract][Full Text] [Related]
14. Apathy symptoms induced by low-dose venlafaxine: Two cases.
Sato S; Sodeyama N; Matsuzaki A; Shiratori Y
Neuropsychopharmacol Rep; 2020 Jun; 40(2):196-197. PubMed ID: 32267090
[TBL] [Abstract][Full Text] [Related]
15. Venlafaxine induced QTc interval prolongation in a therapeutic dose.
Bavle A
Asian J Psychiatr; 2015 Aug; 16():63-4. PubMed ID: 26187237
[TBL] [Abstract][Full Text] [Related]
16. Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis.
Renoux C; Lix LM; Patenaude V; Bresee LC; Paterson JM; Lafrance JP; Tamim H; Mahmud SM; Alsabbagh MW; Hemmelgarn B; Dormuth CR; Ernst P;
Clin J Am Soc Nephrol; 2015 Oct; 10(10):1716-22. PubMed ID: 26231193
[TBL] [Abstract][Full Text] [Related]
17. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
[TBL] [Abstract][Full Text] [Related]
18. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants May Make for Depressing Surgery.
Oberg TJ; Eftekhari K; Anderson RL
Ophthalmic Plast Reconstr Surg; 2015; 31(4):334. PubMed ID: 26164037
[No Abstract] [Full Text] [Related]
20. Anterior chamber parameters measured by the Pentacam CES after uneventful phacoemulsification in normotensive eyes.
Uçakhan OO; Ozkan M; Kanpolat A
Acta Ophthalmol; 2009 Aug; 87(5):544-8. PubMed ID: 18786130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
